Search research articles
Contact Us
Filters
Showing results (61-70 of 119) with videos related to
Page
of 12
Sort By:
Breast Cancer Research and Treatment
|
August 13, 1999
Association of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapy
P Viens, J Jacquemier, V J Bardou, et al.
Breast Cancer Research : BCR
|
February 20, 2019
Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression
C Van Berckelaer, C Rypens, P van Dam, et al.
Bone Marrow Transplantation
|
November 20, 2003
Occult tumor cell contamination in patients with stage II/III breast cancer receiving sequential high-dose chemotherapy
F Viret, C Chabannon, D Sainty, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 24, 2012
Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial
A Patrikidou, S Chabaud, I Ray-Coquard, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 7, 2017
Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study
A de Nonneville, A Gonçalves, C Zemmour, et al.
The Journal of Pathology
|
May 29, 1998
Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis
J D Jacquemier, F M Penault-Llorca, F Bertucci, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 18, 2019
Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group
Marie Meurer, A Floquet, I Ray-Coquard, et al.
Bulletin Du Cancer
|
January 22, 1998
[Intensive chemotherapy with autologous stem cell transplantation in ovarian cancers: analysis of 67 patients treated at the Paoli-Calmettes Institute and a review of the literature]
P Viens, F Bertucci, G Gravis, et al.
British Journal of Cancer
|
July 29, 2010
Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis
A Dufresne, F Bertucci, N Penel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 14, 2011
Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome
N Penel, A Italiano, I Ray-Coquard, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 119) with videos related to
Sort By:
Page
of 12
Breast Cancer Research and Treatment
|
August 13, 1999
Association of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapy
P Viens, J Jacquemier, V J Bardou, et al.
Breast Cancer Research : BCR
|
February 20, 2019
Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression
C Van Berckelaer, C Rypens, P van Dam, et al.
Bone Marrow Transplantation
|
November 20, 2003
Occult tumor cell contamination in patients with stage II/III breast cancer receiving sequential high-dose chemotherapy
F Viret, C Chabannon, D Sainty, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 24, 2012
Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial
A Patrikidou, S Chabaud, I Ray-Coquard, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 7, 2017
Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study
A de Nonneville, A Gonçalves, C Zemmour, et al.
The Journal of Pathology
|
May 29, 1998
Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis
J D Jacquemier, F M Penault-Llorca, F Bertucci, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 18, 2019
Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group
Marie Meurer, A Floquet, I Ray-Coquard, et al.
Bulletin Du Cancer
|
January 22, 1998
[Intensive chemotherapy with autologous stem cell transplantation in ovarian cancers: analysis of 67 patients treated at the Paoli-Calmettes Institute and a review of the literature]
P Viens, F Bertucci, G Gravis, et al.
British Journal of Cancer
|
July 29, 2010
Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis
A Dufresne, F Bertucci, N Penel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 14, 2011
Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome
N Penel, A Italiano, I Ray-Coquard, et al.
Page
of 12